MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Study on feasibility to develop a central nervous system (CNS) Leucine-rich repeat kinase 2 (LRRK2) PET tracer

    Z. Zeng, P. Miller, T. Graham, L. Tong, D. Hesk, W. Li, E. Hostetler (West Point, PA, USA)

    Objective: To assess feasibility of developing a CNS LRRK2 PET tracer. Background: LRRK2 enzyme belongs to the leucine-rich repeat kinase family. Pathogenic mutations in the…
  • 2018 International Congress

    Evaluation of bradykinesia in Parkinson’s disease using a computerised evolutionary algorithm

    R. Newby, S. Muhamed, P. Kempster, J. Alty, S. Jamieson, J. Cosgrove, S. Smith (Leeds, United Kingdom)

    Objective: Application of a computerised algorithm to kinematic motor recordings to distinguish parkinsonian bradykinesia from normal movement. Background: Bradykinesia, the only obligatory physical sign for…
  • 2018 International Congress

    Combined Neurite Orientation Dispersion and Density Imaging and Myelin Imaging Provide New Insights to White Matter Changes of the Neurocognitive-psychiatric Disorder in Parkinson’s Disease

    C. Andica, K. Kamagata, T. Hatano, A. Saito, Y. Takenaka, T. Ogawa, G. Oyama, Y. Shimo, M. Hori, N. Hattori, S. Aoki (Tokyo, Japan)

    Objective: To identify white matter (WM) changes in PD with neurocognitive-psychiatric symptoms (NPS) using neurite orientation dispersion and density imaging (NODDI) and magnetization transfer saturation…
  • 2018 International Congress

    Validation of the new diagnostic criteria for fatigue in Parkinson’s disease

    A. Mosejova, T. Merovova, I. Straka, V. Han, Z. Gdovinova, P. Valkovic, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of this study was to validate the new diagnostic criteria for fatigue1 in Parkinson’s disease patients. Background: Case definition and diagnostic criteria…
  • 2018 International Congress

    Burden of Eye disease in Parkinson’s disease (PD)

    N. Butt, M. Khwaja, A. Chatterjee (Reading, United Kingdom)

    Objective: To review the burden of eye pathologies in patients with Parkinson’s disease. Background: Parkinson’s disease and eye problems are common in older patients. Alterations…
  • 2018 International Congress

    Study of prevalence of non-motor symptoms in typical and atypical parkinsonism as compared to age and sex matched healthy controls

    N. Barad, C. Sankhla (Mumbai, India)

    Objective: 1) To study prevalence and clinical characteristics of non-motor symptoms (NMS) in idiopathic parkinson disease (IPD) and atypical Parkinsonism (APD) as compared to age…
  • 2018 International Congress

    Is REM sleep behavior disorder associated with excessive daytime sleepiness in military veterans with Parkinson’s disease?

    A. Sarwar, S. Moore (Houston, TX, USA)

    Objective: To determine if REM sleep behavior disorder (RBD) is associated with excessive daytime sleepiness (ES) in military veterans with Parkinson’s disease (PD). Background: Nearly…
  • 2018 International Congress

    Multimorbidity predicts quality of life but not motor severity in early Parkinson’s disease

    R. Gravell, G. Duncan, T. Khoo, D. Burn, A. Sayer, R. Barker, R. Lawson, A. Yarnall (Newcastle upon Tyne, United Kingdom)

    Objective: To explore the associations between multimorbidity, severity of motor symptoms, and quality of life (QoL) in people with early PD. Background: Multimorbidity is defined…
  • 2018 International Congress

    Gastrointestinal Symptoms and Enteric Nerve Dysfunction in A53T Mice

    R. McQuade, P. Rajasekhar, S. Diwakarla, R. Constable, D. Poole, J. Berger, D. Finkelstein, J. Furness (Melbourne, Australia)

    Objective: To investigate the relationship between α synucleinopathy-induced enteric neuropathy and gastrointestinal dysfunction in A53T mice. Background: Approximately 80-90% of PD patients suffer from GI…
  • 2018 International Congress

    Degeneration of vagus nerve but not of accessory and phrenic nerve in Parkinson’s disease revealed by high-resolution ultrasound

    U. Walter, P. Tsiberidou, M. Kersten, A. Storch, M. Löhle (Rostock, Germany)

    Objective: To test the hypothesis that the vagus nerve is measurably atrophic in idiopathic Parkinson’s disease (PD). Background: The vagus nerve is discussed to represent…
  • « Previous Page
  • 1
  • …
  • 140
  • 141
  • 142
  • 143
  • 144
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley